The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure
Open Access
- 9 August 2018
- journal article
- review article
- Published by Uppsala Medical Society in Upsala Journal of Medical Sciences
- Vol. 124 (1), 65-69
- https://doi.org/10.1080/03009734.2018.1490831
Abstract
Heart failure (HF) represents a global pandemic. Although in HF with reduced ejection fraction (HFrEF) randomized controlled trials have provided effective treatments, prognosis still remains poor, with signals of undertreatment. HF with mid-range EF (HFmrEF) has no evidence-based therapy, and its characterization is ongoing. Trials in HF with preserved EF (HFpEF) have failed to provide any effective treatment, but there are several concerns about their design. Thus, current challenges in the HF field are: 1) optimizing the use of existing treatments in HFrEF; 2) developing and proving efficacy of new treatments, and of new use of existing treatments in HFpEF and HFmrEF. Here we describe how registry-based research can improve knowledge addressing the unmet needs in HF, and in particular we focus on the contribution of the Swedish Heart Failure Registry to this field.Keywords
Funding Information
- Stockholms Läns Landsting
- Swedish Research Council (-, 7-, 04-23, 523-, -)
- Swedish Heart and Lung Foundation
- Relypsa Inc.
This publication has 33 references indexed in Scilit:
- Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection FractionJAMA, 2014
- Global Perspectives in Hospitalized Heart Failure: Regional and Ethnic Variation in Patient Characteristics, Management, and OutcomesCurrent Heart Failure Reports, 2014
- Thrombus Aspiration during ST-Segment Elevation Myocardial InfarctionThe New England Journal of Medicine, 2013
- Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection FractionJAMA, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Heart failure registry: a valuable tool for improving the management of patients with heart failureEuropean Journal of Heart Failure, 2009
- Death in Heart FailureCirculation: Heart Failure, 2008
- The validity of a diagnosis of heart failure in a hospital discharge registerEuropean Journal of Heart Failure, 2005
- Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialThe Lancet, 2003
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001